참고문헌 (86)

1. Banton M.C. Inder K.L. Valk E. Rudd C.E. Schneider H. 2014 Rab8 binding to immune cell-specific adaptor LAX facilitates formation of trans-Golgi network-proximal CTLA-4 vesicles for surface expression Mol. Cell. Biol. 34 1486 1499 10.1128/MCB.01331-13 24515439 

   상세보기

2. Barnes M.J. Griseri T. Johnson A.M. Young W. Powrie F. Izcue A. 2013 CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria Mucosal Immunol. 6 324 334 10.1038/mi.2012.75 22910217 

   상세보기

3. Bradshaw J.D. Lu P. Leytze G. Rodgers J. Schieven G.L. Bennett K.L. Linsley P.S. Kurtz S.E. 1997 Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation Biochemistry 36 15975 15982 10.1021/bi971762i 9398332 

   상세보기

4. Brunet J.F. Denizot F. Luciani M.F. Roux-Dosseto M. Suzan M. Mattei M.G. Golstein P. 1987 A new member of the immunoglobulin superfamily--CTLA-4 Nature 328 267 270 10.1038/328267a0 3496540 

   상세보기

5. Chambers C.A. Sullivan T.J. Allison J.P. 1997 Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells Immunity 7 885 895 10.1016/S1074-7613(00)80406-9 9430233 

   상세보기

6. Chao G. Li X. Ji Y. Zhu Y. Li N. Zhang N. Feng Z. Niu M. 2018 CTLA-4 regulates T follicular regulatory cell differentiation and participates in intestinal damage caused by spontaneous autoimmunity Biochem. Biophys. Res. Commun. 505 865 871 10.1016/j.bbrc.2018.09.182 30301533 

   상세보기

7. Chikuma S. Abbas A.K. Bluestone J.A. 2005 B7-independent inhibition of T cells by CTLA-4 J. Immunol. 175 177 181 10.4049/jimmunol.175.1.177 15972645 

   상세보기

8. Chikuma S. Murakami M. Tanaka K. Uede T. 2000 Janus kinase 2 is associated with a box 1-like motif and phosphorylates a critical tyrosine residue in the cytoplasmic region of cytotoxic T lymphocyte associated molecule-4 J. Cell. Biochem. 78 241 250 10.1002/(SICI)1097-4644(20000801)78:2<241::AID-JCB7>3.0.CO;2-K 10842319 

   상세보기

9. Choi J.M. Ahn M.H. Chae W.J. Jung Y.G. Park J.C. Song H.M. Kim Y.E. Shin J.A. Park C.S. Park J.W. 2006 Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation Nat. Med. 12 574 579 10.1038/nm1385 16604087 

   상세보기

10. Choi J.M. Kim S.H. Shin J.H. Gibson T. Yoon B.S. Lee D.H. Lee S.K. Bothwell A.L. Lim J.S. Lee S.K. 2008 Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis Proc. Natl. Acad. Sci. U. S. A. 105 19875 19880 10.1073/pnas.0805198105 19066215 

    상세보기

11. Chuang E. Alegre M.L. Duckett C.S. Noel P.J. Vander Heiden M.G. Thompson C.B. 1997 Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression J. Immunol. 159 144 151 10.1073/pnas.94.17.9273 9200449 

    상세보기

12. Chuang E. Fisher T.S. Morgan R.W. Robbins M.D. Duerr J.M. Vander Heiden M.G. Gardner J.P. Hambor J.E. Neveu M.J. Thompson C.B. 2000 The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A Immunity 13 313 322 10.1016/S1074-7613(00)00031-5 11021529 

    상세보기

13. Chuang E. Lee K.M. Robbins M.D. Duerr J.M. Alegre M.L. Hambor J.E. Neveu M.J. Bluestone J.A. Thompson C.B. 1999 Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases J. Immunol. 162 1270 1277 9973379 

    상세보기

14. Contardi E. Palmisano G.L. Tazzari P.L. Martelli A.M. Fala F. Fabbi M. Kato T. Lucarelli E. Donati D. Polito L. 2005 CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction Int. J. Cancer 117 538 550 10.1002/ijc.21155 15912538 

    상세보기

15. Curran M.A. Montalvo W. Yagita H. Allison J.P. 2010 PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors Proc. Natl. Acad. Sci. U. S. A. 107 4275 4280 10.1073/pnas.0915174107 20160101 

    상세보기

16. Fallarino F. Grohmann U. Hwang K.W. Orabona C. Vacca C. Bianchi R. Belladonna M.L. Fioretti M.C. Alegre M.L. Puccetti P. 2003 Modulation of tryptophan catabolism by regulatory T cells Nat. Immunol. 4 1206 1212 10.1038/ni1003 14578884 

    상세보기

17. Genovese M.C. Becker J.C. Schiff M. Luggen M. Sherrer Y. Kremer J. Birbara C. Box J. Natarajan K. Nuamah I. 2005 Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition N. Engl. J. Med. 353 1114 1123 10.1056/NEJMoa050524 16162882 

    상세보기

18. Glatigny S. Hollbacher B. Motley S.J. Tan C. Hundhausen C. Buckner J.H. Smilek D. Khoury S.J. Ding L. Qin T. 2019 Abatacept targets T follicular helper and regulatory T cells, disrupting molecular pathways that regulate their proliferation and maintenance J. Immunol. 202 1373 1382 10.4049/jimmunol.1801425 30683697 

    상세보기

19. Guntermann C. Alexander D.R. 2002 CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases J. Immunol. 168 4420 4429 10.4049/jimmunol.168.9.4420 11970985 

    상세보기

20. Hodi F.S. O'Day S.J. McDermott D.F. Weber R.W. Sosman J.A. Haanen J.B. Gonzalez R. Robert C. Schadendorf D. Hassel J.C. 2010 Improved survival with ipilimumab in patients with metastatic melanoma N. Engl. J. Med. 363 711 723 10.1056/NEJMoa1003466 20525992 

    상세보기

21. Hu H. Rudd C.E. Schneider H. 2001 Src kinases Fyn and Lck facilitate the accumulation of phosphorylated CTLA-4 and its association with PI-3 kinase in intracellular compartments of T-cells Biochem. Biophys. Res. Commun. 288 573 578 10.1006/bbrc.2001.5814 11676481 

    상세보기

22. Jiang Y. Li Y. Zhu B. 2015 T-cell exhaustion in the tumor microenvironment Cell Death Dis. 6 e1792 10.1038/cddis.2015.162 26086965 

    상세보기

23. Khattri R. Auger J.A. Griffin M.D. Sharpe A.H. Bluestone J.A. 1999 Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses J. Immunol. 162 5784 5791 10229811 

    상세보기

24. Khoury S.J. Rochon J. Ding L. Byron M. Ryker K. Tosta P. Gao W. Freedman M.S. Arnold D.L. Sayre P.H. 2017 ACCLAIM: a randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis Mult. Scler. 23 686 695 10.1177/1352458516662727 27481207 

    상세보기

25. Kim G.R. Kim W.J. Lim S. Lee H.G. Koo J.H. Nam K.H. Kim S.M. Park S.D. Choi J.M. 2021a In vivo induction of regulatory T cells via CTLA-4 signaling peptide to control autoimmune encephalomyelitis and prevent disease relapse Adv. Sci. (Weinh.) 8 2004973 10.1002/advs.202004973 34306974 

    상세보기

26. Kim H.K. Jeong M.G. Hwang E.S. 2021b Post-translational modifications in transcription factors that determine T helper cell differentiation Mol. Cells 44 318 327 10.14348/molcells.2021.0057 33972470 

    원문보기 상세보기

27. Klocke K. Sakaguchi S. Holmdahl R. Wing K. 2016 Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood Proc. Natl. Acad. Sci. U. S. A. 113 E2383 E2392 10.1073/pnas.1603892113 27071130 

    상세보기

28. Kong K.F. Fu G. Zhang Y. Yokosuka T. Casas J. Canonigo-Balancio A.J. Becart S. Kim G. Yates J.R. 3rd Kronenberg M. 3rd 2014 Protein kinase C-eta controls CTLA-4-mediated regulatory T cell function Nat. Immunol. 15 465 472 10.1038/ni.2866 24705298 

    상세보기

29. Kozik P. Francis R.W. Seaman M.N.J. Robinson M.S. 2010 A screen for endocytic motifs Traffic 11 843 855 10.1111/j.1600-0854.2010.01056.x 20214754 

    상세보기

30. Krummel M.F. Allison J.P. 1995 CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation J. Exp. Med. 182 459 465 10.1084/jem.182.2.459 7543139 

    상세보기

31. Larsen C.P. Pearson T.C. Adams A.B. Tso P. Shirasugi N. Strobert E. Anderson D. Cowan S. Price K. Naemura J. 2005 Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties Am. J. Transplant. 5 443 453 10.1111/j.1600-6143.2005.00749.x 15707398 

    상세보기

32. Latek R. Fleener C. Lamian V. Kulbokas E. 3rd Davis P.M. 3rd Suchard S.J. 3rd Curran M. 3rd Vincenti F. 3rd Townsend R. 3rd 2009 Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation Transplantation 87 926 933 10.1097/TP.0b013e31819b5a58 19300198 

    상세보기

33. Lim S. Ho Sohn J. Koo J.H. Park J.W. Choi J.M. 2017 dNP2-ctCTLA-4 inhibits German cockroach extract-induced allergic airway inflammation and hyper-responsiveness via inhibition of Th2 responses Exp. Mol. Med. 49 e362 10.1038/emm.2017.107 28775364 

    상세보기

34. Lim S. Kim W.J. Kim Y.H. Lee S. Koo J.H. Lee J.A. Yoon H. Kim D.H. Park H.J. Kim H.M. 2015 dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis Nat. Commun. 6 8244 10.1038/ncomms9244 26372309 

    상세보기

35. Lim S. Kirkiles-Smith N.C. Pober J.S. Bothwell A.L.M. Choi J.M. 2018 Regulation of human T cell responses by dNP2-ctCTLA-4 inhibits human skin and microvessel graft rejection Biomaterials 183 128 138 10.1016/j.biomaterials.2018.08.049 30165256 

    상세보기

36. Ling V. Wu P.W. Finnerty H.F. Sharpe A.H. Gray G.S. Collins M. 1999 Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders Genomics 60 341 355 10.1006/geno.1999.5930 10493833 

    상세보기

37. Lingel H. Wissing J. Arra A. Schanze D. Lienenklaus S. Klawonn F. Pierau M. Zenker M. Jansch L. Brunner-Weinzierl M.C. 2017 CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation Cell Death Differ. 24 1739 1749 10.1038/cdd.2017.102 28644433 

    상세보기

38. Linsley P.S. Bradshaw J. Greene J. Peach R. Bennett K.L. Mittler R.S. 1996 Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement Immunity 4 535 543 10.1016/S1074-7613(00)80480-X 8673700 

    상세보기

39. Linsley P.S. Brady W. Urnes M. Grosmaire L.S. Damle N.K. Ledbetter J.A. 1991 CTLA-4 is a second receptor for the B cell activation antigen B7 J. Exp. Med. 174 561 569 10.1084/jem.174.3.561 1714933 

    상세보기

40. Linsley P.S. Clark E.A. Ledbetter J.A. 1990 T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1 Proc. Natl. Acad. Sci. U. S. A. 87 5031 5035 10.1073/pnas.87.13.5031 2164219 

    상세보기

41. Linsley P.S. Greene J.L. Brady W. Bajorath J. Ledbetter J.A. Peach R. 1994 Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors Immunity 1 793 801 10.1016/S1074-7613(94)80021-9 7534620 

    상세보기

42. Lo B. Zhang K. Lu W. Zheng L. Zhang Q. Kanellopoulou C. Zhang Y. Liu Z. Fritz J.M. Marsh R. 2015 AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy Science 349 436 440 10.3410/f.725669971.793508623 26206937 

    

43. Marengere L.E. Waterhouse P. Duncan G.S. Mittrucker H.W. Feng G.S. Mak T.W. 1996 Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4 Science 272 1170 1173 10.1126/science.272.5265.1170 8638161 

    상세보기

44. Mead K.I. Zheng Y. Manzotti C.N. Perry L.C. Liu M.K. Burke F. Powner D.J. Wakelam M.J. Sansom D.M. 2005 Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells J. Immunol. 174 4803 4811 10.4049/jimmunol.174.8.4803 15814706 

    상세보기

45. Mease P.J. Gottlieb A.B. van der Heijde D. FitzGerald O. Johnsen A. Nys M. Banerjee S. Gladman D.D. 2017 Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis Ann. Rheum. Dis. 76 1550 1558 10.1136/annrheumdis-2016-210724 28473423 

    상세보기

46. Miyatake S. Nakaseko C. Umemori H. Yamamoto T. Saito T. 1998 Src family tyrosine kinases associate with and phosphorylate CTLA-4 (CD152) Biochem. Biophys. Res. Commun. 249 444 448 10.1006/bbrc.1998.9191 9712716 

    상세보기

47. Olsson C. Riesbeck K. Dohlsten M. Michaelsson E. 1999 CTLA-4 ligation suppresses CD28-induced NF-kappaB and AP-1 activity in mouse T cell blasts J. Biol. Chem. 274 14400 14405 10.1074/jbc.274.20.14400 10318864 

    상세보기

48. Parulekar A.D. Boomer J.S. Patterson B.M. Yin-Declue H. Deppong C.M. Wilson B.S. Jarjour N.N. Castro M. Green J.M. 2013 A randomized controlled trial to evaluate inhibition of T-cell costimulation in allergen-induced airway inflammation Am. J. Respir. Crit. Care Med. 187 494 501 10.1164/rccm.201207-1205OC 23292882 

    상세보기

49. Paterson A.M. Lovitch S.B. Sage P.T. Juneja V.R. Lee Y. Trombley J.D. Arancibia-Carcamo C.V. Sobel R.A. Rudensky A.Y. Kuchroo V.K. 2015 Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity J. Exp. Med. 212 1603 1621 10.1084/jem.20141030 26371185 

    상세보기

50. Pedros C. Canonigo-Balancio A.J. Kong K.F. Altman A. 2017 Requirement of Treg-intrinsic CTLA4/PKCeta signaling pathway for suppressing tumor immunity JCI Insight 2 e95692 10.1172/jci.insight.95692 29212947 

    상세보기

51. Qureshi O.S. Kaur S. Hou T.Z. Jeffery L.E. Poulter N.S. Briggs Z. Kenefeck R. Willox A.K. Royle S.J. Rappoport J.Z. 2012 Constitutive clathrin-mediated endocytosis of CTLA-4 persists during T cell activation J. Biol. Chem. 287 9429 9440 10.1074/jbc.M111.304329 22262842 

    상세보기

52. Qureshi O.S. Zheng Y. Nakamura K. Attridge K. Manzotti C. Schmidt E.M. Baker J. Jeffery L.E. Kaur S. Briggs Z. 2011 Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4 Science 332 600 603 10.1126/science.1202947 21474713 

    상세보기

53. Read S. Greenwald R. Izcue A. Robinson N. Mandelbrot D. Francisco L. Sharpe A.H. Powrie F. 2006 Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo J. Immunol. 177 4376 4383 10.4049/jimmunol.177.7.4376 16982872 

    상세보기

54. Read S. Malmstrom V. Powrie F. 2000 Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation J. Exp. Med. 192 295 302 10.1084/jem.192.2.295 10899916 

    상세보기

55. Sage P.T. Paterson A.M. Lovitch S.B. Sharpe A.H. 2014 The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells Immunity 41 1026 1039 10.1016/j.immuni.2014.12.005 25526313 

    상세보기

56. Sandborn W.J. Colombel J.F. Sands B.E. Rutgeerts P. Targan S.R. Panaccione R. Bressler B. Geboes K. Schreiber S. Aranda R. 2012 Abatacept for Crohn's disease and ulcerative colitis Gastroenterology 143 62 69.e4 10.1053/j.gastro.2012.04.010 22504093 

    상세보기

57. Schneider H. Downey J. Smith A. Zinselmeyer B.H. Rush C. Brewer J.M. Wei B. Hogg N. Garside P. Rudd C.E. 2006 Reversal of the TCR stop signal by CTLA-4 Science 313 1972 1975 10.1126/science.1131078 16931720 

    상세보기

58. Schneider H. Martin M. Agarraberes F.A. Yin L. Rapoport I. Kirchhausen T. Rudd C.E. 1999 Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2 J. Immunol. 163 1868 1879 10438921 

59. Schneider H. Prasad K.V. Shoelson S.E. Rudd C.E. 1995 CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells J. Exp. Med. 181 351 355 10.1084/jem.181.1.351 7807015 

    상세보기

60. Schneider H. Rudd C.E. 2014 Diverse mechanisms regulate the surface expression of immunotherapeutic target ctla-4 Front. Immunol. 5 619 10.3389/fimmu.2014.00619 25538704 

    상세보기

61. Schneider H. Smith X. Liu H. Bismuth G. Rudd C.E. 2008 CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization Eur. J. Immunol. 38 40 47 10.1002/eji.200737423 18095376 

    상세보기

62. Schubert D. Bode C. Kenefeck R. Hou T.Z. Wing J.B. Kennedy A. Bulashevska A. Petersen B.S. Schaffer A.A. Gruning B.A. 2014 Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations Nat. Med. 20 1410 1416 10.1038/nm.3746 25329329 

    상세보기

63. Seidel J.A. Otsuka A. Kabashima K. 2018 Anti-PD-1 and anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations Front. Oncol. 8 86 10.3389/fonc.2018.00086 29644214 

    상세보기

64. Serwas N.K. Hoeger B. Ardy R.C. Stulz S.V. Sui Z. Memaran N. Meeths M. Krolo A. Yuce Petronczki O. Pfajfer L. 2019 Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis Nat. Commun. 10 3106 10.1038/s41467-019-10812-x 31308374 

    상세보기

65. Shiratori T. Miyatake S. Ohno H. Nakaseko C. Isono K. Bonifacino J.S. Saito T. 1997 Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2 Immunity 6 583 589 10.1016/S1074-7613(00)80346-5 9175836 

    상세보기

66. Srahna M. Van Grunsven L.A. Remacle J.E. Vandenberghe P. 2006 CTLA-4 interacts with STAT5 and inhibits STAT5-mediated transcription Immunology 117 396 401 10.1111/j.1365-2567.2005.02313.x 16476059 

    상세보기

67. Stumpf M. Zhou X. Bluestone J.A. 2013 The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetes J. Immunol. 190 961 969 10.4049/jimmunol.1201362 23293354 

    상세보기

68. Stumpf M. Zhou X. Chikuma S. Bluestone J.A. 2014 Tyrosine 201 of the cytoplasmic tail of CTLA-4 critically affects T regulatory cell suppressive function Eur. J. Immunol. 44 1737 1746 10.1002/eji.201343891 24648182 

    상세보기

69. Szentpetery A. Heffernan E. Gogarty M. Mellerick L. McCormack J. Haroon M. Elmamoun M. Gallagher P. Kelly G. Fabre A. 2017 Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis Arthritis Res. Ther. 19 158 10.1186/s13075-017-1364-3 28679449 

    상세보기

70. Takahashi T. Tagami T. Yamazaki S. Uede T. Shimizu J. Sakaguchi N. Mak T.W. Sakaguchi S. 2000 Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 J. Exp. Med. 192 303 310 10.1084/jem.192.2.303 10899917 

    상세보기

71. Teft W.A. Chau T.A. Madrenas J. 2009 Structure-Function analysis of the CTLA-4 interaction with PP2A BMC Immunol. 10 23 10.1186/1471-2172-10-23 19405949 

    상세보기

72. Ueda H. Howson J.M. Esposito L. Heward J. Snook H. Chamberlain G. Rainbow D.B. Hunter K.M. Smith A.N. Di Genova G. 2003 Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature 423 506 511 10.1038/nature01621 12724780 

    상세보기

73. Valk E. Rudd C.E. Schneider H. 2008 CTLA-4 trafficking and surface expression Trends Immunol. 29 272 279 10.1016/j.it.2008.02.011 18468488 

    상세보기

74. Verhagen J. Gabrysova L. Shepard E.R. Wraith D.C. 2014 Ctla-4 modulates the differentiation of inducible Foxp3+ Treg cells but IL-10 mediates their function in experimental autoimmune encephalomyelitis PLoS One 9 e108023 10.1371/journal.pone.0108023 25238105 

    상세보기

75. Vijayakrishnan L. Slavik J.M. Illes Z. Greenwald R.J. Rainbow D. Greve B. Peterson L.B. Hafler D.A. Freeman G.J. Sharpe A.H. 2004 An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells Immunity 20 563 575 10.1016/S1074-7613(04)00110-4 15142525 

    상세보기

76. Walunas T.L. Lenschow D.J. Bakker C.Y. Linsley P.S. Freeman G.J. Green J.M. Thompson C.B. Bluestone J.A. 1994 CTLA-4 can function as a negative regulator of T cell activation Immunity 1 405 413 10.1016/1074-7613(94)90071-X 7882171 

    상세보기

77. Wang C.J. Heuts F. Ovcinnikovs V. Wardzinski L. Bowers C. Schmidt E.M. Kogimtzis A. Kenefeck R. Sansom D.M. Walker L.S. 2015 CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement Proc. Natl. Acad. Sci. U. S. A. 112 524 529 10.1073/pnas.1414576112 25548162 

    상세보기

78. Waterhouse P. Penninger J.M. Timms E. Wakeham A. Shahinian A. Lee K.P. Thompson C.B. Griesser H. Mak T.W. 1995 Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 Science 270 985 988 10.1126/science.270.5238.985 7481803 

    상세보기

79. Watkins B. Qayed M. McCracken C. Bratrude B. Betz K. Suessmuth Y. Yu A. Sinclair S. Furlan S. Bosinger S. 2021 Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD J. Clin. Oncol. 39 1865 1877 10.1200/JCO.20.01086 33449816 

    상세보기

80. Wei S.C. Sharma R. Anang N.A.S. Levine J.H. Zhao Y. Mancuso J.J. Setty M. Sharma P. Wang J. Pe'er D. 2019 Negative co-stimulation constrains T cell differentiation by imposing boundaries on possible cell states Immunity 50 1084 1098.e10 10.1016/j.immuni.2019.03.004 30926234 

    상세보기

81. Wing K. Onishi Y. Prieto-Martin P. Yamaguchi T. Miyara M. Fehervari Z. Nomura T. Sakaguchi S. 2008 CTLA-4 control over Foxp3+ regulatory T cell function Science 322 271 275 10.1126/science.1160062 18845758 

    상세보기

82. Yang Y. Li X. Ma Z. Wang C. Yang Q. Byrne-Steele M. Hong R. Min Q. Zhou G. Cheng Y. 2021 CTLA-4 expression by B-1a B cells is essential for immune tolerance Nat. Commun. 12 525 10.1038/s41467-020-20874-x 33483505 

    상세보기

83. Yi L.A. Hajialiasgar S. Chuang E. 2004 Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo Int. Immunol. 16 539 547 10.1093/intimm/dxh055 15039384 

    상세보기

84. Zhang H. Dutta P. Liu J. Sabri N. Song Y. Li W.X. Li J. 2019 Tumour cell-intrinsic CTLA4 regulates PD-L1 expression in non-small cell lung cancer J. Cell. Mol. Med. 23 535 542 10.1111/jcmm.13956 30378264 

    상세보기

85. Zhang Y. Allison J.P. 1997 Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein Proc. Natl. Acad. Sci. U. S. A. 94 9273 9278 10.1073/pnas.94.17.9273 9256472 

    상세보기

86. Zheng S.G. Wang J.H. Stohl W. Kim K.S. Gray J.D. Horwitz D.A. 2006 TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells J. Immunol. 176 3321 3329 10.4049/jimmunol.176.6.3321 16517699 

    상세보기